Avidity Partners Management LP / ZNTL
Avidity Partners Management LP’s Zentalis Pharmaceuticals Inc Position
Does Avidity Partners Management LP own Zentalis Pharmaceuticals Inc (ZNTL)? Not currently — the last reported position was 2.10M shares worth $42M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$42M
Q3 2023
Shares
2.10M
% of Portfolio
+1.70%
Quarters Held
14
position exited
Position History ZNTL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 2.10M | $42M | +1.70% |
| Q2 2023 | 2.33M | $66M | +2.30% |
| Q1 2023 | 2.93M | $50M | +1.67% |
| Q4 2022 | 5.15M | $104M | +2.25% |
| Q3 2022 | 4.22M | $91M | +1.86% |
| Q2 2022 | 3.59M | $101M | +2.31% |
| Q1 2022 | 3.18M | $147M | +3.05% |
| Q4 2021 | 2.71M | $228M | +4.84% |
| Q3 2021 | 2.49M | $166M | +3.68% |
| Q2 2021 | 2.16M | $115M | +3.11% |
| Q1 2021 | 1.26M | $55M | +1.51% |
| Q4 2020 | 1.14M | $59M | +1.91% |
| Q3 2020 | 904.1K | $30M | +1.37% |
| Q2 2020 | 674.5K | $32M | +2.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Avidity Partners Management LP’s full portfolio or all institutional holders of ZNTL.